Tegsedi

Hereditary Transthyretin Amyloidosis With Polyneuropthy

Akcea TherapeuticsPhase 4 / Approved

—

Rating in progress

Tegsedi in Hereditary Transthyretin Amyloidosis With Polyneuropthy is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Dormant